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The electrophysiological hallmark of cells and tissues isolated from failing hearts is
prolongation of action potential duration (APD) and conduction slowing. In human studies
and a number of animal models of heart failure, functional downregulation of K currents and
alterations in depolarizing Na and Ca currents and transporters are demonstrated. Alterations
in intercellular ion channels and matrix contribute to heterogeneity of APD and conduction
slowing. The changes in cellular and tissue function are regionally heterogenous particularly
in the heart failure with dyssynchronous LV contraction (DHF). Furthermore, -adrenergic
signaling and modulation of ionic currents is blunted in heart failure.
Cardiac resynchronization therapy (CRT) partially reversed the DHF-induced down-
regulation of K current and improved Na channel gating. CRT signiﬁcantly improved Ca
homeostasis especially in myocytes from late-activated, lateral wall, and restores the DHF-
induced blunted -adrenergic receptor responsiveness. CRT abbreviated DHF-induced
prolongation of APD in the lateral wall myocytes and reduced the LV regional gradient of
APD, and suppressed development of early afterdepolarizations.
In conclusion, CRT partially restores DHF-induced ion channel remodeling, abnormal Ca
homeostasis, blunted -adrenergic response and regional heterogeneity of APD, thus may
suppress ventricular arrhythmias and contribute to the mortality beneﬁt of CRT as well as
improve mechanical performance of the heart.
(J Arrhythmia 2010; 26: 79–90)
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Introduction
Heart failure is highly prevalent, accounting for
more than 250,000 deaths annually in the United
States and 100,000 in Japan. The incidence and
prevalence has continued to increase with the aging
of the population.1,2) Despite remarkable improve-
ments in medical therapy, the prognosis of patients
with myocardial failure remains poor with almost
20% of patients dying within one year of initial
diagnosis and greater than 80% eight-year mortality.
Of the deaths in patients with heart failure, up to
50% are sudden and unexpected; indeed, patients
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with heart failure have 6–9 times the rate of sudden
cardiac death of the general population.1)
Heart failure is associated with anatomic and
functional remodeling of cardiac tissues in both
animal models and humans, which alters cardiac
electrophysiology. Indeed, abnormalities of atrial
and ventricular electrophysiology in diseased human
hearts have been recognized for over four decades.
Remodeling of myocyte electrophysiology in heart
failure is well described; recent data suggests that the
pattern of electrical and mechanical activation may
inﬂuence this remodeling.
Heart Failure and Electrical Remodeling
Prolongation of APD and development of EADs
The hallmark of cells and tissues isolated from
failing hearts independent of the cause is prolon-
gation of action potential duration (APD).3–9) The
action potential reﬂects a delicate balance between
the activity of several depolarizing and repolarizing
ionic currents, transporters, and exchangers, which
are not uniformly expressed in the ventricular wall
(Figure 1). The prolongation of APD in heart failure
is heterogeneous, exaggerating the physiological
inhomogeneity of electrical properties in the failing
heart.4,10) The action potential prolongation in heart
failure is highly arrhythmogenic with frequent
early afterdepolarizations (EADs) that are not
observed in ventricular myocytes isolated from
control hearts.
Kþ channel remodeling
Kþ current downregulation is a regular ﬁnding in
the failing heart. The detailed changes in currents
and channels vary with the model of heart failure;
however, the consistent eﬀect is the generation of
heterogeneous prolongation of APD.
Transient outward Kþ current (Ito)
Although expressed cardiac Kþ channels vary in
diﬀerent species. Transient outward potassium cur-
rent (Ito) down regulation is the most consistent ionic
current change in failing hearts.3,5,6,8,11) As Ito is an
early transient current; it may not directly aﬀect the
ventricular APD in large mammalian hearts as it
does in rodent ventricle. Interestingly, downregula-
tion of Ito in cells isolated from terminally failing
human hearts is not associated with a change in its
voltage dependence or kinetics.3) The molecular
mechanism of Ito downregulation in heart failure is
likely to be multifactorial. Reduced steady-state
levels of Kv4 mRNA are highly correlated with
functional downregulation of Ito in human heart
failure.6,11–14) In a canine model, tachycardia down-
regulates Ito expression, with the Ca
2þ/calmodulin-
dependent protein kinase II (CaMKII) and calcineur-
in/nuclear factor of activated T-cells (NFAT) sys-
tems playing key Ca2þ-sensing and signal-transduc-
ing roles in rate-dependent Ito control.
15)
Inward rectiﬁer Kþ current (IK1)
Reduced inward IK1 density in heart failure may
contribute to prolongation of APD and enhanced
susceptibility to spontaneous membrane depolari-
zations including delayed afterdepolarizations
(DADs)7,10,16,17) Changes in IK1 functional expres-
sion are more variable than Ito, and controversial.
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Figure 1 Ionic basis for altered ventricular action potential by heart failure.
Schematic of inward and outward ionic currents, pumps, and exchangers, which inscribe the mammalian ventricular action potential. A
schematic of the time course of each current is shown (left), and the gene product that underlies the current is indicated (right).
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Even within the same experimental model of heart
failure induction (e.g. pacing-tachycardia), inconsis-
tencies have been observed across species: reduced
IK1 density in canine
5,10) but no change in rabbit.18)
In terminal human heart failure, IK1 is signiﬁcantly
reduced at negative voltages,3) but the underlying
basis for such downregulation appears to be post-
transcriptional in light of the absence of changes in
the steady-state level of Kir2.1 mRNA.6)
The molecular basis of IK1 downregulation in
heart failure remains controversial without consistent
changes in the expression of Kir2 family of genes.
Even the speciﬁc subunit(s) that underlie IK1 vary as
function of species and cardiac chamber, although
Kir2.1 and 2.2 knockout19) and Kir2.1 dominant
negative overexpressing mice20) exhibit prolonged
APDs.
Delayed rectiﬁer Kþ currents (IKr and IKs)
The delayed rectiﬁer Kþ currents play a prom-
inent role in the late phase of repolarization,21)
therefore changes in either the slow (IKs) or fast
(IKr) activating components of this current could
contribute signiﬁcantly to action potential prolonga-
tion in heart failure. Reduced IK density, slower
activation, and faster deactivation kinetics have
been observed in hypertrophied feline ventricles.22)
Downregulation of both IKr and IKs have been
reported in a rabbit model of rapid ventricular
pacing heart failure,8) whereas IKs but not IKr was
downregulated in all layers of the left ventricular
myocardium in a canine model of same tachy-
pacing heart failure.10) The molecular basis for IK
down regulation in heart failure remains uncertain.
Previous study measured mRNA levels of the genes
encoding the  subunits for the rapidly (HERG) and
slowly (KvLQT1) activating components of IK in
normal and failing canine hearts and found no
statistical diﬀerence.6)
Ca2þ currents and Ca2þ transients
Altered Ca2þ homeostasis underlies abnormalities
in excitation-contraction coupling and arrhythmic
risk in heart failure. Intracellular [Ca2þ] and the
action potential are intricately linked by a variety of
Ca2þ-mediated cell surface channels and transporters
such as L-type Ca2þ current (ICa-L), IK, Ca2þ-
activated Cl current, and Naþ/Ca2þ exchanger
(NCX). ICa-L density is unchanged or reduced in
heart failure, the latter typically occurring in more
advanced disease.23) Remarkably in human heart
failure baseline ICa-L density is consistently un-
changed;24) although single channel studies suggest
a reduction in channel number with an increase in
open probability perhaps due to altered phosphor-
ylation or subunit composition.25) The molecular
bases of changes in the density of ICa-L are
incompletely understood, subunit mRNA expression
in heart failure is variable.26) The complexity of the
molecular Ca channel remodeling is highlighted by
reports of isoform switching of both 1C27) and 
subunits in the failing heart.28)
The amplitude of the calcium transient (CaT) and
its rate of decay are reduced in intact preparations
and cells isolated from failing ventricles.29) System-
atic comparisons of the CaT proﬁle and dynamics in
cells isolated from diﬀerent regions of the failing
heart are limited. Sarcoplasmic reticulum Ca2þ-
ATPase (SERCA2a), its inhibitor phospholamban
(PLN) and NCX are primary mediators of Ca2þ
removal from the cytoplasm. In heart failure,
ventricular myocytes exhibit a greater reliance on
NCX for removal of Ca2þ from the cytosol and an
increase in NCX function,30) which leads to defec-
tive SR Ca2þ loading.31) Altered NCX function in
heart failure signiﬁcantly inﬂuences CaT and action
potential dynamics.32) SR Ca2þ release is also
defective in the failing heart and is associated with
altered regulation of the ryanodine receptor
(RyR).33) Hyperphosphorylation of RyR by protein
kinase A34) or CaMKII35) may increase diastolic
Ca2þ leak and generate spontaneous Ca2þ waves
underlying triggered arrhythmias in heart failure.
The role of RyR regulation and gating in altered
systolic function and arrhythmic risk in heart failure
remains controversial.36–38) Recently, increased in-
ositol 1,4,5-trisphosphate receptors (InsP3Rs) ex-
pression has been suggested to be a general
mechanism that underlies remodeling of Ca2þ
signaling during heart disease, and in particular, in
triggering ventricular arrhythmia during hypertro-
phy.39) On the other hand, CaMKII contributes to
cardiac decompensation by enhancing RyR2-medi-
ated SR Ca2þ leak and that attenuating CaMKII
activation can limit the progression to heart fail-
ure.40) The heart failure-mediated alterations in
RyR2 function mimic the changes caused by post-
translational modiﬁcation by reactive oxygen spe-
cies, thus redox modiﬁcation of RyR may contribute
to SR Ca2þ leak in chronic heart failure.41)
Naþ channel and late INa
Studies of Naþ current (INa) in a canine infarct
model of heart failure revealed a signiﬁcant down
regulation of the current, an acceleration of its
inactivation properties, and a slowing of its recovery
from inactivation in myocytes isolated from the
infarct border zone.42) Normal impulse formation
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and conduction depend on the fast inward INa. Also,
an increase in the late component of Na current
(late INa) can markedly prolong APD and promote
polymorphic VT. Therefore, changes in INa density
and kinetics may predispose to arrhythmias either by
disrupting conduction and/or prolonging repolariza-
tion.
In a canine model of ischemic heart failure,
signiﬁcant downregulation of INa, acceleration of its
inactivation properties, and slowing of its recovery
from inactivation were observed.42) A signiﬁcant
increase in the late INa was demonstrated in human
and canine heart failure.43,44) A recent study has
shown that intracellular Ca2þ CaMKII signaling
increases late INa by slowing inactivation kinetics
and shifting steady state inactivation.45–47) The
consequence of increased Naþ inﬂux or decreased
eﬄux in heart failure particularly in the setting of
regionally variable lengthening of the APD is
heterogenous cytosolic Naþ loading and subsequent
activation of ‘reverse mode’ NCX. NCX functioning
in the reverse mode in response to increased [Naþ]i
may be adaptive promoting an increase inﬂux in
activator Ca2þ (Figure 2).
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Figure 2 Intracellular Ca2þ cycling and associated signaling pathways in cardiomyocytes.
On a beat-by-beat basis, a CaT is elicited by the inﬂux of a small amount of Ca2þ through the ICa-L and the
subsequent large-scale Ca2þ release from the SR through the ryanodine receptor (RyR). During diastole,
cytosolic Ca2þ is taken up into the SR by the phospholamban (PLN)-regulated SERCA2a pump. -adrenergic
receptor (-AR)-mediated PKA stimulation regulates this Ca2þ cycling by phosphorylating ICa-L, RyR, and
PLN. In normal hearts, sympathetic stimulation activates the 1-adrenergic receptor, which in turn stimulates
the production of cAMP by adenylyl cyclase and thereby activates PKA. PKA phosphorylates PLN and RyR,
both of which contribute to an increased intracellular CaT and enhanced cellular contractility. PP1 and PP2A
regulate the dephosphorylation process of these Ca2þ regulatory proteins (RyR, PLN and ICa-L). The PLN
hypophosphorylation inhibits SERCA2a activity, thereby decreasing SR Ca2þ uptake. The increased Ca2þ
level in the cytosol activates CaMKII, which aﬀects the functions of RyR and PLN. Activation or deactivation
of these molecules at a node in the signaling cascade aﬀects beat-by-beat Ca2þ cycling, and such maneuvers
have recently been highlighted as potential new therapeutic strategies against heart failure. Increased INCX,
reduced IK1 and residual coupling to -AR signaling may predispose to arrhythmogenic DADs.
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There are no consistent changes in cardiac Naþ
channel subunit expression in heart failure, however,
aberrant splicing of Nav1.5 transcripts has been
reported in failing human ventricular myocardium.48)
Changes in INa are likely to depend on the speciﬁc
disease etiology, and may have profound implica-
tions for arrhythmogenesis given the relative abun-
dance and importance of this current to wavefront
propagation.
Connexin and Purkinje ﬁber remodeling in heart
failure
Slowed intraventricular conduction is a prominent
feature of heart failure and is associated with a
reduction in the density, altered distribution and
post-translational modiﬁcation of the major cardiac
gap junction protein (connexin 43, Cx43).49) Similar
ﬁndings have been observed in hypertrophied and
ischemic human ventricular myocardium, Cx43 is
downregulated and redistributed from the interca-
lated disk to the entire cell border (lateraliza-
tion),50–52) a pattern observed in early cardiac
development. Downregulation and lateralization of
Cx43 in heart failure49) is progressive with duration
of tachypacing53) and associated with conduction
slowing. The mechanism of Cx43 downregulation is
not completely understood but may involve altered
rennin-angiotensin signaling54,55) changes in binding
partners56,57) or altered membrane domain localiza-
tion.58) In tachypacing-induced heart failure, Cx43
down regulation is associated with a reduction in
Cx43 mRNA.
Synchronous activation of the ventricles requires
conduction over the His-Purkinje network. Ionic
current remodeling is distinct in diﬀerent regions of
the failing heart. In heart failure changes in ionic
currents of Purkinje cell include a reduction of Ito
and IK1 density with slowing of ICa-L decay. There
were no signiﬁcant changes in IKr or IKs but Purking
cell exhibit a reduction in repolarizing reserve in
heart failure manifest by APD prolongation and
exaggerated prolongation of the duration in the
presence of class III antiarrhythmic drugs. In
Purkinje ﬁbers downregulation of KV4.3, KV3.4,
Kir2.1 mRNA and protein was observed consistent
with the Kþ current changes.59) Pacing induced heart
failure in the canine model slowed conduction in
Purkinje ﬁber false tendons with an associated
reduction in NaV1.5, Cx40, Cx43 and phospho-
Cx43 protein levels. Immunohistochemistry revealed
reduced Cx40, Cx43 and phospho-Cx43 protein at
the intercalated disk.59) The changes in electrophy-
siological properties of Purkinje ﬁber may serve as a
substrate for ventricular arrhythmia; moreover, re-
duction in conduction in the Purkinje network may
result in dyssynchronous activation of the ventricle
and progression of the heart failure phenotype.
CRT and Reverse Electrical Remodeling
In heart failure with dyssynchronous contraction
(DHF), bi-ventricular (V) pacing referred to as CRT
improves symptoms and reduces mortality in subsets
of patients,60) CRT is widely applied in patients with
DHF, but the electrophysiological consequences of
CRT are not well understood. Therefore, to answer
these questions, using a canine model of pacing-
induced DHF and CRT we investigated these
electrical diﬀerences and mechanistic insights in
cellular, molecular and genetic level.
CRT and arrhythmic events
Is CRT pro-arrhythmic or anti-arrhythmic? Soon
after starting bi-V pacing, QT prolongation and
development of Torsades de pointes, the arrhythmia
characteristic of the long QT syndrome, has been
reported.61) LV epicardial pacing further increased
QTc and JTc intervals compared to Bi-V pacing.62)
In an acute study using a canine wedge preparation,
reversal of activation by the epicardial pacing
compared to the endocardial pacing increased QT,
JT interval and transmural dispersion of repolariza-
tion, creating the substrate for TdP under long-QT
condition.63) On the other hand, whether chronic
CRT alters the QT interval and QT dispersion, and
whether such changes relate to the risk of developing
arrhythmic events are still controversial.64)
In patients with advanced heart failure and a
prolonged QRS interval, CRT decreases the com-
bined risk of death from any cause or ﬁrst hospital-
ization and, when combined with an ICD, signiﬁ-
cantly reduces mortality.65) Compared with ICD-
only, CRT with deﬁbrillator (CRT-D) prevents heart
failure events in relatively asymptomatic patients
with low ejection fraction.66) ICD strongly suppresses
sudden cardiac death but cannot prevent arrhythmic
events, and continuous RV pacing rather results in
adverse LV remodeling and reduce systolic func-
tion.67) On the contrary, some small clinical studies
have shown ventricular arrhythmias were decreased
especially in patients with CRT responder during the
initial 12 months after implant.68,69) Therefore, CRT
is expected to have some beneﬁcial eﬀects not only
in heart failure but also in arrhythmias.
CRT and regional effects on action potentials
and ionic currents
Action potential prolongation in DHF is most
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prominent in cells isolated from the late-activated
lateral LV wall. CRT signiﬁcantly shortens the
action potential in lateral myocytes and reduces the
LV regional heterogeneity in APD (Figure 3).13)
Action potential prolongation in DHF is highly
arrhythmogenic with frequent EADs that were not
observed in myocytes isolated from control hearts.
CRT dramatically reduces the frequency of EADs
in cells isolated from both the anterior and lateral
LV.
The mechanisms of regional action potential
remodeling in the DHF and CRT are controversial.
At the molecular level, tumor necrosis factor-
(TNF-) and CaMKII were increased in DHF
prominently in the lateral wall and these diﬀerences
were absent in CRT.70) TNF- decreases Ito and
prolongs the APD in rat ventricular myocytes.71)
Recently, Xie et al. suggested an increased oxidative
stress in heart failure induced CaMKII activation and
triggers of ventricular arrhythmias.72) CaMKII inﬂu-
ences Ca2þ current, SR function,73,74) and increases
persistent Naþ current45–47) resulting in prolongation
of APD.75) It is possible and indeed likely, that other
regional alterations in Ca2þ handling or increased
persistent Naþ current contribute to regional dif-
ferences in the APD and action potential proﬁle in
DHF, and the regionally-speciﬁc eﬀects of bi-V
pacing on this phenotype.
Kþ current changes associated with CRT are
variable (Figure 4). The down regulation of Ito is
regionally uniform in the left ventricle in DHF and is
unique among regulated Kþ currents in heart failure
in that it is not reversed by CRT. In parallel, Kv4.3
and KChIP2 mRNA and protein expression are down
regulated in DHF without restoration by CRT.13)
CRT even in the setting of continued heart failure
partially restores IK1 density and decreases mem-
brane resistance and in the setting of improved Ca2þ
handling in CRT may reduce the frequency of
arrhythmogenic DADs. Kir2.1 mRNA and protein
levels are partially restored by CRT in the canine
model; suggesting that diﬀerent mechanisms of
regulation of current are operative in some animal
models and human HF. CRT partially restores DHF-
induced downregulation of IK density in both
anterior and lateral LV myocytes without a signiﬁ-
cant change in mRNA or protein levels of KvLQT1
or minK compared with DHF, whereas ERG mRNA
level was restored by CRT in either the anterior or
lateral LV wall.13)
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Figure 3 Regional heterogeneity of action potential and Ca transient in DHF and its restoration by CRT.
A: DHF prolongs action potential duration (APD), reduces peak amplitude and prolongs decay of Ca transient (CaT) especially in the cells
isolated from LV lateral wall. CRT abbreviates DHF-induced prolongation of APD and restores amplitude and decay of CaT in the lateral
cells, thus reduced regional heterogeneity of repolarization and Ca handling. B: Frequency of early afterdepolarizations (EADs) in
myocytes from DHF are higher than in normal cells, whereas CRT signiﬁcantly reduces the frequency of EADs.
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CRT restores Ca2þ current and handling
In DHF there are intraventricular regional changes
in ICa-L that are partially restored by CRT.
13) DHF
produced a reduction peak ICa-L density and slowed
current decay in myocytes isolated from the late-
activated lateral LV wall. In contrast, peak ICa-L
density in anterior myocytes was increased com-
pared with non-failing controls, thus DHF produced
regional heterogeneity of Ca2þ current density and
kinetics. CRT restored the peak current density but
did not alter the ICa-L decay in the lateral cells,
eliminating the anterior-lateral ICa-L density gradient.
Neither DHF nor CRT exhibit consistent changes in
Ca2þ channel subunit mRNA or protein levels.
In canine pacing DHF, CaT amplitudes are de-
pressed and kinetics slowed particularly in cells
isolated from the late-activated lateral LV myocar-
dium and partially restored by CRT (Figure 3).13) In
DHF, mRNA and protein levels of SERCA2a, PLN
and RyR2 were down regulated and NCX up
regulated without a change in CRT. There were also
no regional diﬀerences in mRNA and protein
expression in any of these mediators of Ca2þ handling
in DHF and CRT, suggesting that the global and
regional diﬀerences of Ca2þ handling function in
DHF and its restoration by CRT are post translational.
The mechanisms underlying the diﬀerences in
regional remodeling of Kþ currents and Ca2þ
handling in DHF remain obscure. Plotnikov et al.
reported that cardiac dyssynchrony by left ventric-
ular pacing (120–150 bpm for 3 weeks) produced a
slower decay of ICa inactivation.
76) Moreover, this
phenomenon was suppressed by a -adrenergic
blockade. These ﬁndings suggest that DHF-induced
changes of ICa inactivation kinetics might be
mediated by regionally heterogeneous -adrenergic
receptor stimulation. Furthermore, the Ca2þ-han-
dling proteins are functionally regulated by phos-
phorylation, prominently by key intracellular en-
zymes protein kinase A and CaMKII,73,74,77) and a
variety of phosphatases which may be regionally
regulated.70)
Reduced -adrenergic receptor (-AR) function is
a key feature of heart failure. CRT restores the DHF-
induced baseline reduction of ICa,L and the blunted
response to -adrenergic (1  2) receptor stim-
ulation. Moreover, CRT improves baseline Ca2þ
handling and its adrenergic responsiveness, which
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Figure 4 CRT partially reverses DHF-induced downregulation of IK1, IK but not Ito.
A-C. DHF signiﬁcantly reduces the inward rectiﬁer IK1, the delayed rectiﬁer (IK) and transient outward K
þ currents (Ito) in both anterior
and lateral cells. CRT partially restores the DHF-induced reduction of IK1 and IK but not Ito in both anterior and lateral cells, D. These
functional changes are consistent with changes in steady state Kþ channel mRNA subunit and protein expressions.
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may contribute to improvement in contractility and
altered arrhythmia susceptibility.78) These electro-
physiological data is consistent to previous molecu-
lar results that CRT increased 1=2-AR ratio. And,
this restoration is the result of augmentation of 1
receptor abundance and reduction in Gi signaling
mediated by an increase in the inhibitory regulator of
G protein signaling, RGS3, in CRT (Figure 5).79)
Gene expression changes by CRT
Several studies have described regional changes in
signaling and protein expression in DHF, notably in
stress-response kinases and cytokines with enhanced
levels in the late-activated, lateral wall.49,70,80) In
some instances CRT can reverse these changes and
produce salutary eﬀects on overall LV function.70) In
order to better understand the breadth of signaling
changes, transcriptomic changes in DHF and CRT
have demonstrated that genes in mitochondrial
energetic pathways are similarly over represented
in the lists of downregulated genes in the failing
LV.81) In contrast, genes localized in nucleus and
related to transcriptional regulation are over repre-
sented in the genes up regulated in failing LV.
A microarray study comparing intraventricular
changes in gene expression in DHF and CRT
revealed that dyssynchrony-induced changes in gene
expression were more pronounced in the anterior
compared with the lateral LV. The genes that
exhibited regional heterogeneity with dyssynchrony
are involved in critical cellular processes such as
metabolic pathways, extracellular matrix remodel-
ing, and myocardial stress responses. Remarkably,
dyssynchrony-induced regional expression changes
were reversed to levels in normal hearts by CRT,
with prominent reversal of dysregulation of expres-
sion of transcripts with metabolic and cell signaling
function (Figure 6).82)
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Figure 5 CRT restores DHF-induced blunted -AR responsiveness.
A: Peak L-type Ca2þ current (ICa) at baseline, after isoproterenol (ISO: 1þ2) or zinterol +CGP-29712A (2) AR stimulation. CRT
restored DHF-induced blunted response to -AR (1  2) stimulation. B: Both 1 and 2 mRNA expressions were decreased in DHF,
whereas 2 remained reduced but 1 was increased in CRT, thus CRT increased 1=2-AR ratio. C: Protein regulation of Gi and RGS
proteins. Membrane Gi was increased in DHF and CRT, whereas RGS2 and RGS3 were markedly upregulated in CRT but not in DHF.
D: Schematic crosstalk of 1 and 2-AR signaling pathway. CRT suppressed DHF-induced enhanced Gi signaling by upregulation of
RGS2 and RGS3.
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Conclusions
Electrophysiological remodeling of the failing
heart involves changes in both active membrane
properties of heart cells and network attributes of the
myocardium. The pattern of electrical activation and
mechanical contraction impact the cellular and tissue
physiology and all seem to exaggerate the normal
heterogeneity of electrophysiological properties of
the heart when it is failing. The remodeling poses
unique and complex challenges to the treatment of
arrhythmias in the failing heart. Studies of antiar-
rhythmic therapy have targeted ion channels and the
cardiac action potential as well as changes in the
cardiac interstitium with variable success.
CRT alters electrical activation of the failing heart
that exhibits intraventricular conduction delays and
resynchronizes mechanical contraction. CRT un-
doubtedly beneﬁts some patients, improving symp-
toms of heart failure and reduces sudden death when
implemented with deﬁbrillator therapy. The reversal
of the exaggerated electrophysiological heterogene-
ity of the failing heart would suggest that CRT is
antiarrhythmic, however this has yet to be demon-
strated clinically.
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